Patent classifications
G16B50/00
Method for the Analysis of Minimal Residual Disease
Provided herein is a method for sequence analysis that comprises analyzing PCR reactions that each contain different portions of the same sample, wherein at least some of the primer pairs are in more than one PCR reaction and at least one of the PCR reactions contains some but not all of the primer pairs of the other reaction(s).
Method for the Analysis of Minimal Residual Disease
Provided herein is a method for sequence analysis that comprises analyzing PCR reactions that each contain different portions of the same sample, wherein at least some of the primer pairs are in more than one PCR reaction and at least one of the PCR reactions contains some but not all of the primer pairs of the other reaction(s).
Identifying knowledge gaps utilizing cognitive network meta-analysis
Techniques for identifying missing evidence are provided. A plurality of documents, each comprising digitally encoded natural language text data, is received. The plurality of documents is processed to determine a plurality of pair-wise comparisons between a plurality of therapies, where each of the plurality of pair-wise comparisons indicate a relative efficacy of at least one therapy in the plurality of therapies, as compared to at least one other therapy in the plurality of therapies. A knowledge graph is generated based at least in part on aggregating the plurality of pair-wise comparisons, and the knowledge graph is analyzed to identify one or more knowledge gaps within the knowledge graph. Finally, at least an indication of the identified one or more knowledge gaps is output.
Identifying knowledge gaps utilizing cognitive network meta-analysis
Techniques for identifying missing evidence are provided. A plurality of documents, each comprising digitally encoded natural language text data, is received. The plurality of documents is processed to determine a plurality of pair-wise comparisons between a plurality of therapies, where each of the plurality of pair-wise comparisons indicate a relative efficacy of at least one therapy in the plurality of therapies, as compared to at least one other therapy in the plurality of therapies. A knowledge graph is generated based at least in part on aggregating the plurality of pair-wise comparisons, and the knowledge graph is analyzed to identify one or more knowledge gaps within the knowledge graph. Finally, at least an indication of the identified one or more knowledge gaps is output.
Systems and methods for identifying cancer treatments from normalized biomarker scores
Techniques for generating therapy biomarker scores and visualizing same. The techniques include determining, using a patient's sequence data and distributions of biomarker values across one or more reference populations, a first set of normalized scores for a first set of biomarkers associated with a first therapy, and a second set of normalized scores for a second set of biomarkers associated with a second therapy, generating a graphical user interface (GUI) including a first portion associated with the first therapy and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the first set of normalized scores; and a second portion associated with a second therapy and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the second set of normalized scores; and displaying the generated GUI.
Systems and methods for identifying cancer treatments from normalized biomarker scores
Techniques for generating therapy biomarker scores and visualizing same. The techniques include determining, using a patient's sequence data and distributions of biomarker values across one or more reference populations, a first set of normalized scores for a first set of biomarkers associated with a first therapy, and a second set of normalized scores for a second set of biomarkers associated with a second therapy, generating a graphical user interface (GUI) including a first portion associated with the first therapy and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the first set of normalized scores; and a second portion associated with a second therapy and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the second set of normalized scores; and displaying the generated GUI.
Integrated consumer genomic services
The present invention provides a novel approach for consumer-driven interaction with sequencing data or genomic information. Sequencing data access, for users with a variety of access and permissions, may be mediated by a central hub. The hub may also facilitate access to the sequencing data for third party software applications. The hub may also provide data analysis or may have access to analyzed data to use such data in providing a user interface for a genome owner or for non-owner secondary users of the system.
Integrated consumer genomic services
The present invention provides a novel approach for consumer-driven interaction with sequencing data or genomic information. Sequencing data access, for users with a variety of access and permissions, may be mediated by a central hub. The hub may also facilitate access to the sequencing data for third party software applications. The hub may also provide data analysis or may have access to analyzed data to use such data in providing a user interface for a genome owner or for non-owner secondary users of the system.
RECONSTRUCTION OF SPARSE BIOMEDICAL DATA
The invention features a computer-implemented biological data prediction method executed by one or more processors including receiving, by the one or more processors, a biomedical data set comprising biomedical data corresponding to a plurality of detected analytes in a biological sample collected from a set of patients at intermittent time intervals, the biomedical data set having a first plurality of feature dimensions; processing, by the one or more processors, the biomedical data set to generate a low-rank tensor having a second plurality of feature dimensions, wherein the second plurality of feature dimensions can be lower than the first plurality of feature dimensions; generating, by the one or more processors, predicted biomedical data along the second plurality of feature dimensions corresponding to the intermittent time intervals; and creating a reconstructed biomedical data set including the predicted biomedical data and the biomedical data along the first plurality of feature dimensions.
RECONSTRUCTION OF SPARSE BIOMEDICAL DATA
The invention features a computer-implemented biological data prediction method executed by one or more processors including receiving, by the one or more processors, a biomedical data set comprising biomedical data corresponding to a plurality of detected analytes in a biological sample collected from a set of patients at intermittent time intervals, the biomedical data set having a first plurality of feature dimensions; processing, by the one or more processors, the biomedical data set to generate a low-rank tensor having a second plurality of feature dimensions, wherein the second plurality of feature dimensions can be lower than the first plurality of feature dimensions; generating, by the one or more processors, predicted biomedical data along the second plurality of feature dimensions corresponding to the intermittent time intervals; and creating a reconstructed biomedical data set including the predicted biomedical data and the biomedical data along the first plurality of feature dimensions.